Clinicians Should Look Beyond NGS When Delivering Precision Oncology: Joshua K. Sabari, MD | AJMC
Clinicians Should Look Beyond NGS When Delivering Precision Oncolo…
6 days ago
ajmc.com
Halloween Eye Injuries Should Be Seen by an Eye Doctor: Craig See, MD | AJMC
Halloween Eye Injuries Should Be Seen by an Eye Doctor: Craig See…
1 week ago
ajmc.com
Exploring Teclistamab’s Potential in Combination Therapy for Multiple Myeloma: Marc S. Raab, MD, PhD | AJMC
Exploring Teclistamab’s Potential in Combination Therapy for Multiple …
1 week ago
ajmc.com
Walking Carefully With Masks, Avoiding Projectiles Are Key in Protecting Eyes on Halloween: Douglas Lazzaro, MD | AJMC
Walking Carefully With Masks, Avoiding Projectiles Are Key in Pr…
1 week ago
ajmc.com
Understanding the Current State of LDL-C Goal Attainment and Barriers to Adequate Control in Hyperlipidemia | AJMC
Understanding the Current State of LDL-C Goal Attainment and Barrie…
6 days ago
ajmc.com
Triple-Class Exposed Relapsed and Refractory Multiple Myeloma | AJMC
Triple-Class Exposed Relapsed and Refractory Multiple Myeloma | AJMC
Jan 4, 2021
ajmc.com
Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Daily Activity Impairment in Patients with Seasonal Allergic Rhinitis | AJMC
Effect of Fexofenadine HC1 on Quality of Life and Work, Classroo…
Apr 1, 1999
ajmc.com
Prevalence, Costs, and Treatment of Alzheimer's Disease and Related …
Aug 1, 2001
ajmc.com
Dr David M. O'Malley on Identifying Which Patients Will Respond to P…
Mar 24, 2019
ajmc.com
Dr Swaminathan P. Iyer on Efficacy, Safety of CD70-Targeted CAR T-C…
Jun 11, 2022
ajmc.com
AURORA 2 Study of Voclosporin in LN Treatment | AJMC
Dec 15, 2022
ajmc.com
Dr Mrinal Gounder: Nirogacestat Approval Provides First-in-Class …
Dec 8, 2023
ajmc.com
Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney …
Oct 25, 2020
ajmc.com
An Overview of B-Cell Malignancies | AJMC
Jan 21, 2020
ajmc.com
How SURPASS-CVOT Spotlights Tirzepatide for Cardiovascular Out…
Jul 28, 2023
ajmc.com
Dr Neil Gross: Cemiplimab Has Great Potential in cSCC | AJMC
Dec 5, 2022
ajmc.com
Dr Jonathan Silverberg: Trial Washout Periods Are Methodologi…
Apr 23, 2021
ajmc.com
Explaining Molecular Residual Disease | AJMC
Dec 22, 2021
ajmc.com
Dr Martin Makary Outlines Advantages, Disadvantages of Gr…
Jun 2, 2019
ajmc.com
Using Lenalidomide and Pomalidomide in RRMM Managem…
Jun 21, 2022
ajmc.com
FDA Approves Fifth Neulasta Biosimilar | AJMC
Jun 2, 2022
ajmc.com
Dr John Burke: POLARIX Shows Marked Improvement in Patient O…
Dec 14, 2021
ajmc.com
Dr Patrick Burnett Explains Mechanism of Action for Roflumil…
Aug 25, 2022
ajmc.com
Dr David Rosmarin on Tailored Biologic Treatments, New Vitiligo …
Mar 27, 2022
ajmc.com
New CAR T Trial in MM Aims for Triple Receptor Targeting | AJMC
Aug 24, 2024
ajmc.com
Dr Laurie Slovarp Outlines the Benefits of Behavioral Cough Sup…
Jun 12, 2021
ajmc.com
POD1UM-303/InterAACT 2: Potentially Practice-Changing Fin…
Sep 14, 2024
ajmc.com
PROVE-HF Trial Overview | AJMC
Jan 5, 2021
ajmc.com
Early Diagnosis Vital to Myasthenia Gravis Treatment: Richard J. Now…
6 months ago
ajmc.com
2024 ASPC Congress on CVD Prevention to Be Held in August | …
Jul 8, 2024
ajmc.com
See more videos
Static thumbnail place holder